Cohort Dashboard

GP2’s mission is to further understand the genetic architecture of Parkinson’s disease (PD) through genotyping diverse participant groups and studying highly suspected monogenic forms of PD. In support of this mission, we continue to collect diverse cohorts from around the world through collaboration and openly sharing data, processes, and results. Explore the dashboard below to understand our milestones achieved so far, and continue to visit this page as data will be updated monthly.

Total Global Data

0
Unique Locations
0
Cohorts
0
Samples Expected
0
Samples Completed

Last Updated: January 14, 2023 | Original design by GP2 Hackathon 2021 Team: Mary Makarious, Kajsa Brolin, Yeajin Song, and Anastasia Illarionova

Showing 7 of 227 cohort studies.

UGCPD

Center for Neurodiagnostic Therapeutic Services, Metropolitan Medical Center | Manila, The Philippines
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

0 Completed out of 70 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

0 Completed out of 30 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

0 Completed out of 100 Expected

UMUDALL

University of Michigan Udall Center | Michigan, United States
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

91 Completed out of 110 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

3 Completed out of 0 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

94 Completed out of 110 Expected
Ancestry Breakdown for Samples Completed
Show

UPENN U19 Cohort

University of Pennsylvania | Philadephia, United States
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

279 Completed out of 800 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

18 Completed out of 200 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

297 Completed out of 1,000 Expected
Ancestry Breakdown for Samples Completed
Show

VET-PD

Seattle Institute for Biomedical and Clinical Research | Seattle, United States
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

0 Completed out of 500 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

0 Completed out of 500 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

0 Completed out of 1,000 Expected

VIPD

University College London | London, United Kingdom
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

562 Completed out of 485 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

120 Completed out of 80 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

682 Completed out of 565 Expected
Ancestry Breakdown for Samples Completed
Show

Yale Medical School

Yale Medical School | New Haven, United States
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

13 Completed out of 20 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

36 Completed out of 20 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

49 Completed out of 40 Expected
Ancestry Breakdown for Samples Completed
Show

YOPDFL (Young Onset Parkinson's Disease)

Norman Fixel Institute for Neurological Diseases | Gainesville, United States
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

0 Completed out of 150 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

0 Completed out of 0 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

0 Completed out of 150 Expected

Submit a Cohort

If you would like to collaborate with GP2, reach out to submit a cohort or get more information on how to become a member.

Request AMP® PD Data Set

As GP2 completes cohort genotyping, all data is shared through the secured AMP® PD platform. Register to request access to this data.

Discover GP2 Members from Around the Globe

Explore the organizational members that make our research possible through their collaboration and contribution of samples and data.